Echo-Guided vs Fluoroscopy-Guided Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis(ECHO-TAVR)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 212 participants.

Also called NCT07317804

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 212 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07317804
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07317804. Randomized; no masking; primary purpose treatment. Start 2026-04-26 (anticipated); primary completion 2028-07-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Echo-Guided vs Fluoroscopy-Guided Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis(ECHO-TAVR)
Acronym
ECHO-TAVR
Condition
Aortic Stenosis
Condition
TAVI
Condition
TAVI(Transcatheter Aortic Valve Implantation)
Intervention (Device)
Echocardiographic guidance
Intervention (Device)
Fluoroscopic guidance
Lead sponsor
China National Center for Cardiovascular Diseases (class: other government)

Record details

Record id
cardio:ct-nct07317804
Content hash
89969c41aeaf40606c07f80ad65c627ba95099fcb13d455e84508fcdaa9c7526